PRODUCTS
640×640
LbpAI for Cervical Cytology

LbpA.I. for Cervical Cytology is an advanced AI-driven system that automatically captures and reconstructs high-resolution, full-slide digital images from liquid-based cytology specimens. Leveraging powerful deep learning algorithms, it performs rapid and comprehensive screening, accurately identifying and localizing a wide spectrum of potentially abnormal epithelial cells, inflammatory cells, and pathogenic microorganisms. By automatically triaging negative cases, LbpA.I. significantly reduces the workload of cytopathologists while maintaining high diagnostic sensitivity.


Clinicians benefit from an intuitive interface that highlights suspicious cells for quick visual verification, streamlining the diagnostic workflow and enabling faster report turnaround. The system is trained on a robust dataset comprising over one million expertly annotated fields of view and cellular images, allowing for the high-precision classification of more than ten clinically significant cell types and microorganisms.

Tailored for the specific demands of cervical cytology, LbpA.I. enhances diagnostic accuracy, supports early detection of cervical lesions, and promotes standardization in cytological evaluation.


640×640
FEATURES
Intelligence
Informatization
Standardization
Digitalization
Automation
Personalization
Precision
Characteristics

Training

Training Dataset: Over 2.5 million annotated fields of vi

AI Clinical Validation

  • Multi-center Testing: Conducted in 16 major hospitals in 2021

  • Real-world Sample Testing: Includes cervical cytology and ThinPrep samples

  • Benchmark Testing: Compared against mainstream cytological workflows and manual slide reviews

  • Outcome: AI accuracy in detecting LSIL: 99.2%–100%


Quantities and Ratios

  • NILM : ASC-US : LSIL : ASC-H : HSIL+ (SCC+HSIL+AIS) : AGC+ (ADC+AGC) : Microorganisms = 28:6:5:2:5:1:1

  • Number of Cases: 23,000


Robust Data & Deep Learning 

ew

Cell Annotations: 6.5 million+ cells across 1.5 million+ slides

Detection Capability: Covers 13 major cervical cell types and common microorganisms

Clinical Deployment: System has analyzed over 500,000 real-world cases


Performance Metrics

 Metric  Hospital-Based Slides  Cervical Screening Slides 
 Negative Recall (All) 65%–80% 96.0%
 Positive Recall (All) 98.7% 99.0%
 Positive Recall (LSIL+) 99.3% 99.6%
 Positive Recall (ASCH+) 99.5% 99.8%


Key Clinical Findings

  • LSIL Sensitivity: >99.2%

  • HSIL Sensitivity: 100%

  • ASCH+Sensitivity: >96.7%


  • Specificity (Liquid-Based Cytology): 85%

  • Specificity (Membrane-Based Cytology): 70%



ONLINE MESSAGE
Please enter your contact information and we will get back to you as soon as possible.
submit
×